Skip to main content
Erschienen in: Osteoporosis International 3/2017

08.11.2016 | Original Article

Surgery alters parameters of vitamin D status and other laboratory results

verfasst von: N. Binkley, D. Coursin, D. Krueger, P. Iglar, J. Heiner, R. Illgen, M. Squire, J. Lappe, P. Watson, K. Hogan

Erschienen in: Osteoporosis International | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Summary

Fracture liaison services often perform laboratory testing, but these results may be altered by surgery. In 40 hip arthroplasty patients, many laboratory parameters of bone health relevance were reduced by 8–22% on the first post-operative day. Laboratory results obtained in the immediate post-surgery interval do not reliably ascertain baseline status.

Introduction

As secondary causes of osteoporosis are common, fracture liaison services often perform laboratory testing in the immediate post-fracture interval. We hypothesized that laboratory results obtained shortly after surgery may not accurately ascertain baseline status. If true, such alterations might confound subsequent fracture prevention efforts.

Methods

Patients undergoing elective total hip arthroplasty were studied as a surrogate for hip fracture patients. Blood and urine were obtained 2 weeks before surgery, before anesthetic induction, on post-operative day one, and 6 weeks after surgery. Serum total and free 25-hydroxyvitamin D (25(OH)D), vitamin D-binding protein (DBP), calcium, creatinine, albumin (Alb), alkaline phosphatase (ALP), plasma hemoglobin (Hgb) and urinary DBP/creatinine ratio (UDBP/Cr) were measured.

Results

Forty volunteers (28 women; 12 men) with mean age of 65.7 [8.7] years were studied. Laboratory results were stable from 2 weeks before to the day of surgery. On the first day after surgery, total 25(OH)D, DBP, calcium, creatinine, ALP, and Alb declined 8–22% (p < 0.0001); free 25(OH)D and Hgb declined by 8 and 15% (p < 0.01), respectively; and UDBP/Cr increased 32% (p < 0.01). Using a 25(OH)D <30 ng/mL threshold, vitamin D inadequacy prevalence increased from 38% before surgery to 68% the day after (p < 0.001). All laboratory values returned to baseline at 6 weeks after surgery.

Conclusions

Laboratory values are reduced immediately following elective total hip arthroplasty. Testing at that time does not accurately ascertain baseline status and may lead to elevated estimates of vitamin D inadequacy, incorrect interventions, and misallocation of healthcare resources.
Literatur
1.
Zurück zum Zitat Anonymous (2001) Osteoporosis prevention, diagnosis and therapy NIH consensus development panel on osteoporosis prevention, diagnosis and therapy. J Am Med Assoc 285:785–795CrossRef Anonymous (2001) Osteoporosis prevention, diagnosis and therapy NIH consensus development panel on osteoporosis prevention, diagnosis and therapy. J Am Med Assoc 285:785–795CrossRef
2.
Zurück zum Zitat Leslie WD, Morin SN (2014) Osteoporosis epidemiology 2013: implications for diagnosis, risk assessment, and treatment. Curr Opin Rheumatol 26:440–446CrossRefPubMed Leslie WD, Morin SN (2014) Osteoporosis epidemiology 2013: implications for diagnosis, risk assessment, and treatment. Curr Opin Rheumatol 26:440–446CrossRefPubMed
3.
Zurück zum Zitat Sattui SE, Saag KG (2014) Fracture mortality: associations with epidemiology and osteoporosis treatment. Nat Rev Endocrinol 10:592–602CrossRefPubMed Sattui SE, Saag KG (2014) Fracture mortality: associations with epidemiology and osteoporosis treatment. Nat Rev Endocrinol 10:592–602CrossRefPubMed
4.
Zurück zum Zitat Si L, Winzenberg TM, de Graaff B, Palmer AJ (2014) A systematic review and meta-analysis of utility-based quality of life for osteoporosis-related conditions. Osteoporos Int 25:1987–1997CrossRefPubMed Si L, Winzenberg TM, de Graaff B, Palmer AJ (2014) A systematic review and meta-analysis of utility-based quality of life for osteoporosis-related conditions. Osteoporos Int 25:1987–1997CrossRefPubMed
5.
Zurück zum Zitat Hernlund E, Svedbom A, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Kanis JA (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. Arch Osteoporos 8:136CrossRefPubMedPubMedCentral Hernlund E, Svedbom A, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Kanis JA (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. Arch Osteoporos 8:136CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382CrossRefPubMed Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382CrossRefPubMed
7.
Zurück zum Zitat Johnell O, Kanis JA, Oden A, Sernbo I, Redlund-Johnell I, Petterson C, De Laet C, Jonsson B (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int 15:175–179CrossRefPubMed Johnell O, Kanis JA, Oden A, Sernbo I, Redlund-Johnell I, Petterson C, De Laet C, Jonsson B (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int 15:175–179CrossRefPubMed
8.
Zurück zum Zitat Lyles KW, Colon-Emeric CS, Magaziner JS et al (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357:1799–1809CrossRefPubMed Lyles KW, Colon-Emeric CS, Magaziner JS et al (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357:1799–1809CrossRefPubMed
9.
Zurück zum Zitat Cummings SR, San Martin J, McClung MR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. [Erratum appears in N Engl J Med. 2009 Nov 5;361(19):1914] N Engl J Med 361:756–765CrossRefPubMed Cummings SR, San Martin J, McClung MR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. [Erratum appears in N Engl J Med. 2009 Nov 5;361(19):1914] N Engl J Med 361:756–765CrossRefPubMed
10.
Zurück zum Zitat Solomon DH, Johnston SS, Boytsov NN, McMorrow D, Lane JM, Krohn KD (2014) Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011. J Bone Miner Res 29:1929–1937CrossRefPubMedPubMedCentral Solomon DH, Johnston SS, Boytsov NN, McMorrow D, Lane JM, Krohn KD (2014) Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011. J Bone Miner Res 29:1929–1937CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Akesson K, Marsh D, Mitchell PJ, McLellan AR, Stenmark J, Pierroz DD, Kyer C, Cooper C (2013) Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int 24:2135–2152CrossRefPubMedPubMedCentral Akesson K, Marsh D, Mitchell PJ, McLellan AR, Stenmark J, Pierroz DD, Kyer C, Cooper C (2013) Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int 24:2135–2152CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Eisman JA, Bogoch ER, Dell R, Harrington JT, McKinney RE, McLellan A, Mitchel PJ, Silverman S, Singleton R, Siris E (2012) Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. J Bone Miner Res 27:2039–2046CrossRefPubMed Eisman JA, Bogoch ER, Dell R, Harrington JT, McKinney RE, McLellan A, Mitchel PJ, Silverman S, Singleton R, Siris E (2012) Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. J Bone Miner Res 27:2039–2046CrossRefPubMed
13.
Zurück zum Zitat Miller AN, Lake AF, Emory CL (2015) Establishing a fracture liaison service: an orthopaedic approach. J Bone Joint Surg Am 97:675–681CrossRefPubMed Miller AN, Lake AF, Emory CL (2015) Establishing a fracture liaison service: an orthopaedic approach. J Bone Joint Surg Am 97:675–681CrossRefPubMed
14.
Zurück zum Zitat Dell R, Greene D, Schelkun SR, Williams K (2008) Osteoporosis disease management: the role of the orthopaedic surgeon. J Bone Joint Surg 90(suppl 4):188–194CrossRefPubMed Dell R, Greene D, Schelkun SR, Williams K (2008) Osteoporosis disease management: the role of the orthopaedic surgeon. J Bone Joint Surg 90(suppl 4):188–194CrossRefPubMed
15.
Zurück zum Zitat Mirza F, Canalis E (2015) Management of endocrine disease: secondary osteoporosis: pathophysiology and management. Eur J Endocrinol 173:R131–R151CrossRefPubMedPubMedCentral Mirza F, Canalis E (2015) Management of endocrine disease: secondary osteoporosis: pathophysiology and management. Eur J Endocrinol 173:R131–R151CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Bogoch ER, Elliot-Gibson V, Wang RY, Josse RG (2012) Secondary causes of osteoporosis in fracture patients. J Orthop Trauma 26:e145–e152CrossRefPubMed Bogoch ER, Elliot-Gibson V, Wang RY, Josse RG (2012) Secondary causes of osteoporosis in fracture patients. J Orthop Trauma 26:e145–e152CrossRefPubMed
18.
Zurück zum Zitat Louw JA, Werbeck A, Louw ME, Kotze TJ, Cooper R, Labadarios D (1992) Blood vitamin concentrations during the acute-phase response. Crit Care Med 20:934–941CrossRefPubMed Louw JA, Werbeck A, Louw ME, Kotze TJ, Cooper R, Labadarios D (1992) Blood vitamin concentrations during the acute-phase response. Crit Care Med 20:934–941CrossRefPubMed
19.
Zurück zum Zitat Navarro LH, Bloomstone JA, Auler JO Jr et al (2015) Perioperative fluid therapy: a statement from the international Fluid Optimization Group. Perioperative medicine (London, England) 4:3CrossRef Navarro LH, Bloomstone JA, Auler JO Jr et al (2015) Perioperative fluid therapy: a statement from the international Fluid Optimization Group. Perioperative medicine (London, England) 4:3CrossRef
20.
21.
Zurück zum Zitat Lensmeyer GL, Wiebe DA, Binkley N, Drezner MK (2006) HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays. Clin Chem 52:1120–1126CrossRefPubMed Lensmeyer GL, Wiebe DA, Binkley N, Drezner MK (2006) HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays. Clin Chem 52:1120–1126CrossRefPubMed
23.
Zurück zum Zitat LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J (1999) Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. J Am Med Assoc 281:1505–1511CrossRef LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J (1999) Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. J Am Med Assoc 281:1505–1511CrossRef
24.
Zurück zum Zitat LeBoff MS, Hawkes WG, Glowacki J, Yu-Yahiro J, Hurwitz S, Magaziner J (2008) Vitamin D-deficiency and post-fracture changes in lower extremity function and falls in women with hip fractures. Osteoporos Int 19:1283–1290CrossRefPubMedPubMedCentral LeBoff MS, Hawkes WG, Glowacki J, Yu-Yahiro J, Hurwitz S, Magaziner J (2008) Vitamin D-deficiency and post-fracture changes in lower extremity function and falls in women with hip fractures. Osteoporos Int 19:1283–1290CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Reid D, Toole BJ, Knox S, Talwar D, Harten J, O’Reilly DS, Blackwell S, Kinsella J, McMillan DC, Wallace AM (2011) The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr 93:1006–1011CrossRefPubMed Reid D, Toole BJ, Knox S, Talwar D, Harten J, O’Reilly DS, Blackwell S, Kinsella J, McMillan DC, Wallace AM (2011) The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr 93:1006–1011CrossRefPubMed
26.
Zurück zum Zitat Waldron JL, Ashby HL, Cornes MP, Bechervaise J, Razavi C, Thomas OL, Chugh S, Deshpande S, Ford C, Gama R (2013) Vitamin D: a negative acute phase reactant. J Clin Pathol 66:620–622CrossRefPubMed Waldron JL, Ashby HL, Cornes MP, Bechervaise J, Razavi C, Thomas OL, Chugh S, Deshpande S, Ford C, Gama R (2013) Vitamin D: a negative acute phase reactant. J Clin Pathol 66:620–622CrossRefPubMed
27.
Zurück zum Zitat Schwartz JB, Lai J, Lizaola B, Kane L, Markova S, Weyland P, Terrault NA, Stotland N, Bikle D (2014) A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations. J Clin Endocrinol Metab 99:1631–1637CrossRefPubMedPubMedCentral Schwartz JB, Lai J, Lizaola B, Kane L, Markova S, Weyland P, Terrault NA, Stotland N, Bikle D (2014) A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations. J Clin Endocrinol Metab 99:1631–1637CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Henriksen VT, Rogers VE, Rasmussen GL, Trawick RH, Momberger NG, Aguirre D, Barker T (2014) Pro-inflammatory cytokines mediate the decrease in serum 25(OH)D concentrations after total knee arthroplasty? Med Hypotheses 82:134–137CrossRefPubMed Henriksen VT, Rogers VE, Rasmussen GL, Trawick RH, Momberger NG, Aguirre D, Barker T (2014) Pro-inflammatory cytokines mediate the decrease in serum 25(OH)D concentrations after total knee arthroplasty? Med Hypotheses 82:134–137CrossRefPubMed
29.
Zurück zum Zitat Santonocito C, De Loecker I, Donadello K, Moussa MD, Markowicz S, Gullo A, Vincent JL (2014) C-reactive protein kinetics after major surgery. Anesth Analg 119:624–629CrossRefPubMed Santonocito C, De Loecker I, Donadello K, Moussa MD, Markowicz S, Gullo A, Vincent JL (2014) C-reactive protein kinetics after major surgery. Anesth Analg 119:624–629CrossRefPubMed
30.
Zurück zum Zitat Barker T, Martins TB, Kjeldsberg CR, Trawick RH, Hill HR (2012) Circulating interferon-gamma correlates with 1,25(OH)D and the 1,25(OH)D-to-25(OH)D ratio. Cytokine 60:23–26CrossRefPubMed Barker T, Martins TB, Kjeldsberg CR, Trawick RH, Hill HR (2012) Circulating interferon-gamma correlates with 1,25(OH)D and the 1,25(OH)D-to-25(OH)D ratio. Cytokine 60:23–26CrossRefPubMed
31.
Zurück zum Zitat Bertoldo F, Pancheri S, Zenari S, Boldini S, Giovanazzi B, Zanatta M, Valenti MT, Dalle Carbonare L, Lo Cascio V (2010) Serum 25-hydroxyvitamin D levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion. J Bone Miner Res 25:447–454CrossRefPubMed Bertoldo F, Pancheri S, Zenari S, Boldini S, Giovanazzi B, Zanatta M, Valenti MT, Dalle Carbonare L, Lo Cascio V (2010) Serum 25-hydroxyvitamin D levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion. J Bone Miner Res 25:447–454CrossRefPubMed
32.
Zurück zum Zitat Newens K, Filteau S, Tomkins A (2006) Plasma 25-hydroxyvitamin D does not vary over the course of a malarial infection. Trans R Soc Trop Med Hyg 100:41–44CrossRefPubMed Newens K, Filteau S, Tomkins A (2006) Plasma 25-hydroxyvitamin D does not vary over the course of a malarial infection. Trans R Soc Trop Med Hyg 100:41–44CrossRefPubMed
33.
Zurück zum Zitat Barth JH, Field HP, Mather AN, Plein S (2012) Serum 25 hydroxy-vitamin D does not exhibit an acute phase reaction after acute myocardial infarction. Ann Clin Biochem 49:399–401CrossRefPubMed Barth JH, Field HP, Mather AN, Plein S (2012) Serum 25 hydroxy-vitamin D does not exhibit an acute phase reaction after acute myocardial infarction. Ann Clin Biochem 49:399–401CrossRefPubMed
34.
Zurück zum Zitat Bang UC, Novovic S, Andersen AM, Fenger M, Hansen MB, Jensen JE (2011) Variations in serum 25-hydroxyvitamin D during acute pancreatitis: an exploratory longitudinal study. Endocr Res 36:135–141CrossRefPubMed Bang UC, Novovic S, Andersen AM, Fenger M, Hansen MB, Jensen JE (2011) Variations in serum 25-hydroxyvitamin D during acute pancreatitis: an exploratory longitudinal study. Endocr Res 36:135–141CrossRefPubMed
35.
Zurück zum Zitat Silva MC, Furlanetto TW (2015) Does serum 25-hydroxyvitamin D decrease during acute-phase response? A systematic review. Nutr Res 35:91–96CrossRefPubMed Silva MC, Furlanetto TW (2015) Does serum 25-hydroxyvitamin D decrease during acute-phase response? A systematic review. Nutr Res 35:91–96CrossRefPubMed
37.
Zurück zum Zitat Fakler JK, Grafe A, Dinger J, Josten C, Aust G (2016) Perioperative risk factors in patients with a femoral neck fracture - influence of 25-hydroxyvitamin D and C-reactive protein on postoperative medical complications and 1-year mortality. BMC Musculoskelet Disord 17:51CrossRefPubMedPubMedCentral Fakler JK, Grafe A, Dinger J, Josten C, Aust G (2016) Perioperative risk factors in patients with a femoral neck fracture - influence of 25-hydroxyvitamin D and C-reactive protein on postoperative medical complications and 1-year mortality. BMC Musculoskelet Disord 17:51CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Maier GS, Maus U, Lazovic D, Horas K, Roth KE, Kurth AA (2016) Is there an association between low serum 25-OH-D levels and the length of hospital stay in orthopaedic patients after arthroplasty?. J Orthop Traumatol Maier GS, Maus U, Lazovic D, Horas K, Roth KE, Kurth AA (2016) Is there an association between low serum 25-OH-D levels and the length of hospital stay in orthopaedic patients after arthroplasty?. J Orthop Traumatol
39.
Zurück zum Zitat Barker T, Martins TB, Hill HR, Kjeldsberg CR, Trawick RH, Weaver LK, Traber MG (2011) Low vitamin D impairs strength recovery after anterior cruciate ligament surgery. J Evid Based Complementary Altern Med 16:201–209CrossRef Barker T, Martins TB, Hill HR, Kjeldsberg CR, Trawick RH, Weaver LK, Traber MG (2011) Low vitamin D impairs strength recovery after anterior cruciate ligament surgery. J Evid Based Complementary Altern Med 16:201–209CrossRef
40.
Zurück zum Zitat Amrein K, Schnedl C, Holl A et al (2014) Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. JAMA 312:1520–1530CrossRefPubMed Amrein K, Schnedl C, Holl A et al (2014) Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. JAMA 312:1520–1530CrossRefPubMed
41.
Zurück zum Zitat Przybelski R, Agrawal S, Krueger D, Engelke JA, Walbrun F, Binkley N (2008) Rapid correction of low vitamin D status in nursing home residents. Osteoporos Int 19:1621–1628CrossRefPubMed Przybelski R, Agrawal S, Krueger D, Engelke JA, Walbrun F, Binkley N (2008) Rapid correction of low vitamin D status in nursing home residents. Osteoporos Int 19:1621–1628CrossRefPubMed
42.
Zurück zum Zitat Ross AC, Manson JE, Abrams SA et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the institute of medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53–58CrossRefPubMed Ross AC, Manson JE, Abrams SA et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the institute of medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53–58CrossRefPubMed
43.
Zurück zum Zitat Holick MF, Binkley N, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 96:1911–1930CrossRefPubMed Holick MF, Binkley N, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 96:1911–1930CrossRefPubMed
Metadaten
Titel
Surgery alters parameters of vitamin D status and other laboratory results
verfasst von
N. Binkley
D. Coursin
D. Krueger
P. Iglar
J. Heiner
R. Illgen
M. Squire
J. Lappe
P. Watson
K. Hogan
Publikationsdatum
08.11.2016
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 3/2017
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-016-3819-9

Weitere Artikel der Ausgabe 3/2017

Osteoporosis International 3/2017 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.